Alendronate Sodium/Colecalciferol | Interleukin Related interleukin-related.com

Product Name :
Alendronate Sodium/Colecalciferol

Search keywords :
Alendronic acid

drugId :
null

Target Vo:
Vitamin D receptor

Target Vo Short Name :
VDR

Moa_Name:
Osteoclasts inhibitors

First Approval Country :
United States

First Approval Date Filter:
2005

Origin Company_Name :
Merck Sharp & Dohme Corp

Active Company_Name :
Merck Sharp & Dohme Ltd

Active Indication_Name:
Osteoporosis

In Active Indication_Name:
Vitamin D Deficiency

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Gantenerumab Protocol
AKT1 Rabbit mAb Technical Information
PI 3 Kinase p85 alpha Antibody: PI 3 Kinase p85 alpha Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 84 kDa, targeting to PI 3 Kinase p85 alpha. It can be used for WB,ICC/IF,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts